High Detection Rate of Rotavirus Infection Among Children Admitted with Acute Gastroenteritis to Six Public Hospitals in Luanda Province After the Introduction of Rotarix® Vaccine: A Cross-Sectional Study
Viruses · 2024
DOI: 10.3390/v16121949 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Viruses, 2024. Verfasst von Dikudila Vita und 8 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Agostinho Neto University, Luanda P.O. Box 116, Angola. Hauptthemen laut MEDLINE: Rotavirus Infections, Gastroenteritis, Rotavirus Vaccines, Hospitals, Public. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Abbott Rapid Diagnostics Group.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Rotavirus group A (RVA) is a major cause of pediatric acute gastroenteritis (AGE). Vaccination is an effective public health strategy and Angola implemented it in 2014. This hospital-based study aimed to estimate the prevalence of RVA infection and the severity of AGE in children under five years of age treated at six hospitals in Luanda Province. Between April 2021 and May 2022, 1251 fecal samples were screened by an immunochromatographic rapid test (SD Bioline). Data on socio-demographic profile, nutritional status, and clinical assessment were obtained. The association of RVA infection and AGE severity with possible risk factors was evaluated with a binary logistic regression model. Overall, the detection rate was 57.8% and girls tend to be more often infected than boys (55.2%). Infection was more common in the youngest group (1 to 6 months, 60.3%). Important sources of RVA infection were drinking water kept in tanks (57.9%) and private sanitary facilities with piped water (61%). Surprisingly, according to the Vesikari Scale score, the most severe symptoms were observed in children vaccinated with two doses (80.7%). RVA prevalence remains high despite vaccination, and further studies should address the association between infection sources and disease severity, as well as the causes underlying vaccine (un)effectiveness.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine, Agostinho Neto University, Luanda P.O. Box 116, Angola.
- National Institute for Health Research, Luanda P.O. Box 3635, Angola.
- School of Health Systems and Public Health, Faculty of Health Science, University of Pretoria, Pretoria 0084, South Africa.
- Global Health and Tropical Medicine (GHTM), Institute of Hygiene and Tropical Medicine (IHMT), NOVA University (UNL), 1349-008 Lisbon, Portugal.
- Associate Laboratory for Animal and Veterinary Sciences (AL4AnimalS), Interdisciplinary Center for Research in Animal Health (CIISA), Faculty of Veterinary Medicine, University of Lisbon, 1300-477 Lisbon, Portugal.
ORCID-Profile: Manuel Lemos, Ngiambudulu M Francisco, Celso Cunha, Claudia Istrate
Förderung
- Abbott Rapid Diagnostics Group
Zitieren
APA
Vita, D., Lemos, M., Neto, Z., Evans, M., Francisco, N. M., Fortes, F., Fernandes, E., Cunha, C., & Istrate, C. (2024). High Detection Rate of Rotavirus Infection Among Children Admitted with Acute Gastroenteritis to Six Public Hospitals in Luanda Province After the Introduction of Rotarix® Vaccine: A Cross-Sectional Study. Viruses. https://doi.org/10.3390/v16121949
Vancouver
Vita D, Lemos M, Neto Z, Evans M, Francisco NM, Fortes F, et al. High Detection Rate of Rotavirus Infection Among Children Admitted with Acute Gastroenteritis to Six Public Hospitals in Luanda Province After the Introduction of Rotarix® Vaccine: A Cross-Sectional Study. Viruses. 2024. doi:10.3390/v16121949
BibTeX
@article{Vita2024,
author = {Vita, Dikudila and Lemos, Manuel and Neto, Zoraima and Evans, Mathebula and Francisco, Ngiambudulu M and Fortes, Filomeno and Fernandes, Ema and Cunha, Celso and Istrate, Claudia},
title = {High Detection Rate of Rotavirus Infection Among Children Admitted with Acute Gastroenteritis to Six Public Hospitals in Luanda Province After the Introduction of Rotarix® Vaccine: A Cross-Sectional Study},
journal = {Viruses},
year = {2024},
doi = {10.3390/v16121949}
}
EUVIMED